Susquehanna International Group’s Avalo Therapeutics AVTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-95
| Closed | -$2.74K | – | 5930 |
|
|
2023
Q3 | $2.74K | Buy |
+95
| New | +$2.74K | ﹤0.01% | 5414 |
|
|
2023
Q1 | – | Sell |
-78
| Closed | -$95K | – | 5982 |
|
|
2022
Q4 | $95K | Buy |
+78
| New | +$95K | ﹤0.01% | 4971 |
|
|
2022
Q2 | – | Sell |
-5
| Closed | -$11K | – | 5788 |
|
|
2022
Q1 | $11K | Sell |
5
-4
| -44% | -$8.8K | ﹤0.01% | 5545 |
|
|
2021
Q4 | $45K | Buy |
9
+2
| +29% | +$10K | ﹤0.01% | 5493 |
|
|
2021
Q3 | $46K | Sell |
7
-37
| -84% | -$243K | ﹤0.01% | 5101 |
|
|
2021
Q2 | $412K | Buy |
44
+16
| +57% | +$150K | ﹤0.01% | 4119 |
|
|
2021
Q1 | $246K | Buy |
28
+19
| +211% | +$167K | ﹤0.01% | 4573 |
|
|
2020
Q4 | $68K | Buy |
9
+3
| +50% | +$22.7K | ﹤0.01% | 4573 |
|
|
2020
Q3 | $42K | Buy |
6
+1
| +20% | +$7K | ﹤0.01% | 4240 |
|
|
2020
Q2 | $39K | Hold |
5
| – | – | ﹤0.01% | 4059 |
|
|
2020
Q1 | $36K | Buy |
+5
| New | +$36K | ﹤0.01% | 4261 |
|
|
2019
Q4 | – | Sell |
-4
| Closed | -$35K | – | 4003 |
|
|
2019
Q3 | $35K | Buy |
+4
| New | +$35K | ﹤0.01% | 4241 |
|
|
2019
Q2 | – | Sell |
-20
| Closed | -$329K | – | 4494 |
|
|
2019
Q1 | $329K | Buy |
+20
| New | +$329K | ﹤0.01% | 2186 |
|
|
2018
Q4 | – | Hold |
0
| – | – | – | 3677 |
|
|
2018
Q3 | – | Hold |
0
| – | – | – | 3376 |
|